Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 13.07.2026 2 Ann Neurol 2 BMC Neurol 2 Brain 2 Curr Opin Immunol 9 Diabetes Res Clin Pract 1 J Autoimmun 5 J Neuroimmunol 2 J Neurol 1 J Pediatr 1 J Pediatr Endocrinol Metab 3 Kidney Int 6 Mult Scler 1 Nat Rev Neurol 1 Neurol Clin Pract 1 Neurology 1 PLoS One 3 Proc Natl Acad Sci U S A 2 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. BRENNER J, Crijnen YS, Kulderij I, Olijslagers SHC, et al
   A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.
   Ann Neurol. 2026 Jul 6. doi: 10.1002/ana.78287.
   PubMed         Abstract available
   
   
2. REINDERS EM, Masot-Llima A, Otero-Romero S, Carvajal R, et al
   Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes.
   Ann Neurol. 2026 Jul 6. doi: 10.1002/ana.78275.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. GAO D, Cui L, Yu M, Sun Q, et al
   A novel limited-dose C5 inhibitor add-on as rescue therapy for refractory NMOSD attacks: a practical alternative to conventional multi-dose regimens.
   BMC Neurol. 2026;26:439.
   PubMed         Abstract available
   
   
4. ALSALLOUM T, Alsamman H, Alkerdi R, Alassad G, et al
   Diagnostic overshadowing in primary progressive multiple sclerosis with coexisting tethered cord syndrome and long-standing urological dysfunction: a case report and literature review.
   BMC Neurol. 2026 Jul 6. doi: 10.1186/s12883-026-05161.
   PubMed         Abstract available
   
   

   
   Brain

5. SANDGREN S, Leppert D, Kuhle J
   Propionic acid and neurofilament light chain in multiple sclerosis.
   Brain. 2026 Jul 6:awag192. doi: 10.1093.
   PubMed        
   
   
6. MOSER T, Hitzl W, Lerda-Casaccia T, Unterhofer M, et al
   Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.
   Brain. 2026;149:2286-94.
   PubMed         Abstract available
   
   

   
   Curr Opin Immunol

7. MOUTSOPOULOS HM
   The epithelial cell in Sjogren's syndrome: from passive target to orchestrator of autoimmune reactivity.
   Curr Opin Immunol. 2026;102:102815.
   PubMed         Abstract available
   
   
8. LERNER A, Benzvi C
   The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.
   Curr Opin Immunol. 2026;101:102812.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

9. HONG J, Yin G, Shan G, Li B, et al
   A comprehensive review on the latest progressions of cell-free DNA in diabetes and related microvascular or macrovascular complications.
   Diabetes Res Clin Pract. 2026;238:113348.
   PubMed         Abstract available
   
   
10. CHUJO D, Kawamura T, Kikuchi T, Imagawa A, et al
    The first epidemiological study of presymptomatic type 1 diabetes among first-degree relatives in Japan: PREP-T1D study.
    Diabetes Res Clin Pract. 2026;238:113350.
    PubMed         Abstract available
    
    
11. KIM HY, Ji E, Kim J
    Temporal trends in treatment-requiring microvascular complications in young-onset diabetes: A nationwide population-based study.
    Diabetes Res Clin Pract. 2026;238:113349.
    PubMed         Abstract available
    
    
12. OZAKI K, Nishioka Y, Kamitani F, Nakajima H, et al
    The risk of type 1 diabetes mellitus after COVID-19 and influenza infection: A nationwide cohort and self-controlled case series study.
    Diabetes Res Clin Pract. 2026;238:113366.
    PubMed         Abstract available
    
    
13. ASHRAF T, Lessan N
    GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study.
    Diabetes Res Clin Pract. 2026;238:113369.
    PubMed         Abstract available
    
    
14. BEGBIE TN, Huang MLH, Nanayakkara N, Ma RCW, et al
    Glycation gap size, stability over time and correlates in people with Type 1 diabetes.
    Diabetes Res Clin Pract. 2026;238:113378.
    PubMed         Abstract available
    
    
15. CAPPELLI S, Parenti M, Scappazzoni L, Biasco F, et al
    Retinal microvascular geometry as a biomarker of cognitive function in patients living with type 1 diabetes.
    Diabetes Res Clin Pract. 2026;238:113392.
    PubMed         Abstract available
    
    
16. ABUQWIDER J, Pasolli E, Scida G, Corrado A, et al
    Ultra-processed food intake and its associations with atherogenic dyslipidemia, glycemic control, and gut microbiome features in adults with type 1 diabetes from Southern Italy.
    Diabetes Res Clin Pract. 2026;238:113373.
    PubMed         Abstract available
    
    
17. PULI L, Piona C, Mancioppi V, Passanisi S, et al
    Optimal screening practices for diabetic retinopathy in children and adolescents with type 1 diabetes: a systematic review to inform global screening guidance.
    Diabetes Res Clin Pract. 2026;238:113385.
    PubMed         Abstract available
    
    

    
    J Autoimmun

18. ADAMSEN ML, Rasmussen IE, Printz Lyngbaek MP, Louise L Petersen M, et al
    Randomized controlled single-center clinical trial of high-intensity interval training in patients with systemic lupus erythematosus.
    J Autoimmun. 2026;162:103595.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

19. GLUSCEVIC S, Koc ER, Klisic A, Ziemssen T, et al
    Peripheral redox biomarkers in multiple sclerosis: associations with phenotype, cognition, and fatigue.
    J Neuroimmunol. 2026;419:579018.
    PubMed         Abstract available
    
    
20. DEB A, Nichols J, Olivier AK, Baird J, et al
    Comparison of mannitol versus pertussis toxin to exacerbate active experimental autoimmune encephalomyelitis (EAE).
    J Neuroimmunol. 2026;419:579019.
    PubMed         Abstract available
    
    
21. ZHANG N, Chen H, Mo Y, Wang R, et al
    Thymectomy promotes maintained complete stable remission in myasthenia gravis.
    J Neuroimmunol. 2026;419:579023.
    PubMed         Abstract available
    
    
22. DONG J, Yang CL, Wang SY, Liu C, et al
    Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE-HIF-1alpha-HK2 pathway.
    J Neuroimmunol. 2026;419:579017.
    PubMed         Abstract available
    
    
23. LOPES LMF, Hygino J, Cafasso MOS, Sacramento PM, et al
    Absence of PD-1 expression on T(FH) and T(FC) cell subsets correlates with severity of multiple sclerosis.
    J Neuroimmunol. 2026;419:579012.
    PubMed         Abstract available
    
    

    
    J Neurol

24. INOJOSA H, Masanneck L, Akgun K, Hagler R, et al
    From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.
    J Neurol. 2026;273:454.
    PubMed         Abstract available
    
    
25. FILIPPI M, Grimaldi LME, Brescia Morra V, Conte A, et al
    Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study.
    J Neurol. 2026;273:452.
    PubMed         Abstract available
    
    

    
    J Pediatr

26. MODI AC, Mara CA, O'Donnell H, Schmidt M, et al
    A Pilot Randomized Controlled Clinical Trial to Improve Adherence Barriers for Adolescents with Type 1 Diabetes.
    J Pediatr. 2026 May 22:115155. doi: 10.1016/j.jpeds.2026.115155.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

27. JETTER E, Eason A, Waldmann T, Carr B, et al
    Beyond A(1c): a narrative review of mental health integration in pediatric type 1 diabetes care.
    J Pediatr Endocrinol Metab. 2026;39:629-637.
    PubMed         Abstract available
    
    

    
    Kidney Int

28. FLOEGE J
    The 4-hit hypothesis in IgA nephropathy is getting more complex.
    Kidney Int. 2026 Jul 6:S0085-2538(26)00502-8. doi: 10.1016/j.kint.2026.
    PubMed        
    
    
29. SUZUKI H, Novak J
    Galactose-deficient IgA1 plays a critical role in the formation of pathogenic immune complexes in IgA nephropathy.
    Kidney Int. 2026 Jul 6:S0085-2538(26)00508-9. doi: 10.1016/j.kint.2026.
    PubMed        
    
    
30. ZHANG Y, Barratt J, Zhao MH, Zhang H, et al
    Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.
    Kidney Int. 2026 Jul 6:S0085-2538(26)00492-8. doi: 10.1016/j.kint.2026.
    PubMed        
    
    

    
    Mult Scler

31. ZANOTTO T, Sosnoff JJ
    Preventing frailty in multiple sclerosis is a realistic goal: Yes.
    Mult Scler. 2026 Jul 9:13524585261466113. doi: 10.1177/13524585261466113.
    PubMed        
    
    
32. LIN TY, Bacchetti A, McCormack B, Moussa H, et al
    Association of epiretinal membranes with disability in people with multiple sclerosis.
    Mult Scler. 2026 Jul 6:13524585261446834. doi: 10.1177/13524585261446834.
    PubMed         Abstract available
    
    
33. SYC-MAZUREK S, Chen JJ
    Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?
    Mult Scler. 2026 Jul 6:13524585261464504. doi: 10.1177/13524585261464504.
    PubMed        
    
    
34. LOREFICE L, Zivadinov R
    Preventing frailty in multiple sclerosis is a realistic goal-Commentary.
    Mult Scler. 2026 Jul 9:13524585261466101. doi: 10.1177/13524585261466101.
    PubMed        
    
    
35. SCALFARI A, Bianchi A
    Preventing frailty in multiple sclerosis is a realistic goal - No.
    Mult Scler. 2026 Jul 9:13524585261466107. doi: 10.1177/13524585261466107.
    PubMed        
    
    
36. PAOLICELLI D, Lucisano G, Manni A, Iaffaldano P, et al
    Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).
    Mult Scler. 2026 Jul 4:13524585261457317. doi: 10.1177/13524585261457317.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

37. WOOD H
    Autoantibodies could trigger neurological symptoms of long COVID.
    Nat Rev Neurol. 2026 Jul 9. doi: 10.1038/s41582-026-01243.
    PubMed        
    
    

    
    Neurol Clin Pract

38. NARAYANASWAMI P, Mantegazza R, Barnett-Tapia C, Cortes-Vicente E, et al
    Comprehensive Care Goals in Myasthenia Gravis: Expert Consensus Recommendations Using the RAND/UCLA Appropriateness Method.
    Neurol Clin Pract. 2026;16:e200644.
    PubMed         Abstract available
    
    

    
    Neurology

39. PRESSLER H, Stascheit F, Aigner A, Doksani P, et al
    Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.
    Neurology. 2026;107:e218308.
    PubMed         Abstract available
    
    

    
    PLoS One

40. GROSMANE-BATARAGA A, Saluvera E, Roddate M, Krutovs V, et al
    Evaluation of plasma neurofilament light chain and glial fibrillary acidic protein in myasthenia gravis: A controlled cohort study.
    PLoS One. 2026;21:e0352017.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

41. DE VIRGILIIS F, Barnoud C, He W, Zeng Q, et al
    Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2026;123:e2536812123.
    PubMed         Abstract available
    
    
42. SIMONOVICH JA, Clark RA, Kwiatkowski AJ, Fuchs MJ, et al
    Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetence.
    Proc Natl Acad Sci U S A. 2026;123:e2602536123.
    PubMed         Abstract available
    
    
43. GAO Y, Li X, Dai L, Luo X, et al
    Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-alpha-induced retinal endothelial inflammation.
    Proc Natl Acad Sci U S A. 2026;123:e2533845123.
    PubMed         Abstract available
    
    

    
    Thyroid

44. XIANG P, Mezei M, Latif R, Davies TF, et al
    Stimulating Thyrotropin Receptor Antibodies Enhance the Expression of Both Thyrotropin Receptors and Insulin-Like Growth Factor 1 Receptors in Fibroblasts.
    Thyroid. 2026 Jun 30:10507256261463222. doi: 10.1177/10507256261463222.
    PubMed         Abstract available
    
    
45. BURLACU MC, Bednarczuk T, Lee V, Perros P, et al
    Mild Thyroid Eye Disease-The Most Common yet the Least Studied Presentation of Thyroid Eye Disease.
    Thyroid. 2026 Jun 29:10507256261464556. doi: 10.1177/10507256261464556.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum